Comparing Different Forms of Testosterone for Effective TRT Treatment

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

This article compares various testosterone forms used in TRT, highlighting differences in administration, effectiveness, and side effects to help optimize hormone therapy choices.

# Comparing Different Forms of Testosterone for TRT

Testosterone replacement therapy (TRT) is a common treatment for men with clinically low testosterone levels, also known as hypogonadism. The goal of TRT is to restore testosterone to physiological levels, alleviating symptoms such as low libido, fatigue, depression, and loss of muscle mass. There are several different formulations of testosterone available, each with its own pharmacokinetic profile, administration route, benefits, and potential drawbacks.

This article provides an evidence-based comparison of the main forms of testosterone used in TRT, including injectable esters, transdermal gels and patches, buccal formulations, and subcutaneous pellets. We will discuss dosing protocols, efficacy, safety, and practical considerations to help patients and healthcare providers make informed decisions.

---

Injectable Testosterone Esters

Injectable testosterone esters are among the most widely used and cost-effective formulations for TRT. Common esters include testosterone enanthate, cypionate, and propionate.

Pharmacology and Dosing

  • Testosterone Enanthate and Cypionate: Both have similar half-lives (~4–8 days), allowing for injection every 1-3 weeks. Typical starting doses range from 50-100 mg injected intramuscularly twice weekly or 100-200 mg every 1-2 weeks.
  • Testosterone Propionate: Shorter half-life (~2 days), requiring more frequent injections (2-3 times per week).

    • Advantages

  • Achieves robust serum testosterone levels.
  • Generally more affordable compared to other forms.
  • Flexible dosing allows for tailored therapy.
  • Rapid normalization of symptoms.

    • Drawbacks

  • Peaks and troughs in testosterone levels can lead to fluctuating mood and energy.
  • Injection site pain or irritation.
  • Requires intramuscular injections, which some patients may find uncomfortable.

    • Evidence

    Studies have shown injectable testosterone enanthate and cypionate to effectively improve sexual function, mood, and body composition in hypogonadal men (Bhasin et al., 2018). Monitoring hematocrit, PSA, and estradiol levels is essential to avoid adverse effects.

    ---

    Transdermal Testosterone Gels and Patches

    Transdermal formulations are popular for their ease of use and steady testosterone delivery.

    Types and Dosing

  • Gels: Common brands include AndroGel and Testim. Applied daily to clean, dry skin, typically delivering 50-100 mg of testosterone, with approximately 5-10 mg absorbed systemically.
  • Patches: Applied daily, available in doses such as 2-6 mg/day.

    • Advantages

  • Steady, physiologic testosterone levels avoiding peaks and troughs.
  • Non-invasive with simple daily application.
  • Reduced risk of supraphysiologic serum peaks.
  • Lower risk of mood swings compared to injectables.

    • Drawbacks

  • Skin irritation at the application site.
  • Risk of transference to others through skin contact.
  • Variable absorption influenced by factors like skin condition and temperature.
  • Higher cost compared to injections.

    • Evidence

    Clinical trials demonstrate that transdermal gels normalize testosterone levels and improve hypogonadal symptoms effectively (Wang et al., 2000). Strict adherence to application instructions is crucial to ensure consistent dosing and avoid secondary exposure.

    ---

    Buccal Testosterone

    Buccal systems deliver testosterone through the gum mucosa with adhesive tablets.

    Dosing and Administration

    Applied twice daily to the upper gum for systemic absorption. Typical dosing is 30 mg twice daily.

    Advantages

  • Avoids first-pass metabolism.
  • Provides relatively steady serum testosterone.
  • No risk of skin transference.

    • Drawbacks

  • Local discomfort, gum irritation.
  • Compliance issues due to twice-daily dosing.
  • Less commonly prescribed.

    • Evidence

    Studies show buccal testosterone adequately maintains serum testosterone and improves symptoms (Dobs et al., 1999), though patient preference varies.

    ---

    Subcutaneous Testosterone Pellets

    Testosterone pellets are small implants inserted subcutaneously under the skin every 3-6 months.

    Dosing

    Pellets typically contain 75-150 mg testosterone and are implanted by a healthcare professional. The number of pellets depends on the desired dose and serum testosterone targets.

    Advantages

  • Provides consistent, steady testosterone release for months.
  • Low-maintenance, convenient for patients.
  • Avoids peaks and troughs of injectables.

    • Drawbacks

  • Minor surgical procedure required.
  • Risk of local infection or pellet extrusion.
  • Not easily adjustable once implanted.

    • Evidence

    Pellet therapy has demonstrated efficacy in maintaining therapeutic testosterone levels with high patient satisfaction (Pastuszak et al., 2017). Close follow-up is needed to monitor hormone levels and side effects.

    ---

    Summary Table

    | Formulation | Dosing Frequency | Advantages | Considerations |

    |----------------------------|----------------------------|-----------------------------------|--------------------------------------|

    | Injectable Enanthate/Cypionate | Every 1-2 weeks | Cost-effective, robust levels | Injection discomfort, peaks/troughs |

    | Transdermal Gel | Daily | Non-invasive, steady levels | Skin irritation, transference risk |

    | Transdermal Patch | Daily | Steady levels | Skin irritation, cost |

    | Buccal | Twice daily | Avoids skin, steady levels | Gum irritation, compliance |

    | Subcutaneous Pellets | Every 3-6 months | Convenient, steady release | Surgical insertion, limited adjustability |

    ---

    Practical Protocol and Monitoring

    Starting TRT

  • Confirm hypogonadism with at least two morning fasting total testosterone measurements below reference range.
  • Baseline labs: CBC, PSA, liver function tests, lipid panel.
  • Select formulation based on patient preference, comorbidities, cost, and lifestyle.
  • Educate on administration techniques and side effects.

    • Monitoring During TRT

  • Testosterone levels every 3-6 months initially.
  • Monitor hematocrit to avoid polycythemia (target <54%).
  • PSA and digital rectal exam annually.
  • Assess symptom improvement and side effects.

    • Dose Adjustments

  • Adjust dose to maintain serum testosterone in mid-normal physiologic range (~400-700 ng/dL).
  • For injections, consider dividing doses to reduce peaks/troughs.
  • For gels/patches, adjust daily amount or application site.

    • ---

    Conclusion

    Multiple forms of testosterone for TRT are available, each with unique benefits and limitations. Injectable esters offer cost-effectiveness and flexible dosing but require intramuscular administration and may cause fluctuating hormone levels. Transdermal gels and patches provide steady hormone delivery with ease of use but carry risks of skin irritation and transfer to others. Buccal systems avoid skin-related issues but can cause gum discomfort and require frequent dosing. Subcutaneous pellets deliver long-lasting hormone release but require minor surgery and have less dosing flexibility.

    Selection of an appropriate testosterone formulation should be individualized based on patient preferences, lifestyle, tolerability, and cost considerations. Regardless of delivery method, consistent monitoring and collaboration with a healthcare provider ensure safe and effective treatment outcomes.

    ---

    Disclaimer: This article is for informational purposes only and does not substitute professional medical advice. Individuals considering or currently undergoing TRT should consult their healthcare provider to determine the best treatment option and dosing protocol tailored to their specific needs.

    ---

    References

  • Bhasin S, et al. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018.
  • Wang C, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength in hypogonadal men. J Clin Endocrinol Metab. 2000.
  • Dobs AS, et al. Pharmacokinetics and effects of a testosterone buccal system in hypogonadal men. J Clin Endocrinol Metab. 1999.
  • Pastuszak AW, et al. Testosterone pellets in testosterone replacement therapy: A retrospective analysis of safety and efficacy. Int J Impot Res. 2017.